CAS: 1374248-77-7 - Ubrogepant
Fórmula:C29H26F3N5O3
InChI:InChI=1S/C29H26F3N5O3/c1-16-20(17-6-3-2-4-7-17)11-22(26(39)37(16)15-29(30,31)32)35-25(38)19-10-18-12-28(13-23(18)34-14-19)21-8-5-9-33-24(21)36-27(28)40/h2-10,14,16,20,22H,11-13,15H2,1H3,(H,35,38)(H,33,36,40)/t16-,20-,22+,28+/m1/s1
Clave InChI:InChIKey=DDOOFTLHJSMHLN-ZQHRPCGSSA-N
SMILES:O=C(NC1C(=O)N(CC(F)(F)F)C(C)C(C=2C=CC=CC2)C1)C3=CN=C4C(=C3)CC5(C(=O)NC6=NC=CC=C65)C4
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Ubrogepant REF: 4Z-U-018001CAS: 1374248-77-7 | - - - | A consultar | Mar 04 Jun 24 |
 | Ubrogepant REF: TM-T17194CAS: 1374248-77-7 | 98% | 150,00 €~1.643,00 € | Lun 10 Jun 24 |
 | Ubrogepant REF: 3D-FU165699CAS: 1374248-77-7 | Min. 95% | 645,00 €~1.767,00 € | Lun 29 Jul 24 |
Ref: 4Z-U-018001
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 4 de Junio de 2024
Ubrogepant
CAS:1374248-77-7
Ubrogepant (MK-1602) is an antagonist of calcitonin gene-related peptide receptor that can be used in …
Fórmula:
C29H26F3N5O3
Pureza:
98%
Forma y color:
Solid
Peso molecular:
549.54
Ref: TM-T17194
| 1mg | 150,00 € | |
| 5mg | 369,00 € | |
| 10mg | 583,00 € | |
| 25mg | 914,00 € | |
| 50mg | 1.198,00 € | |
| 100mg | 1.643,00 € | |
| 1ml*10 (DMSO) | 479,00 € |
Entrega estimada en Estados Unidos, el Lunes 10 de Junio de 2024
Ubrogepant
CAS:1374248-77-7
Ubrogepant is a small-molecule drug that is used to treat migraine. It inhibits the activity …
Fórmula:
C29H26F3N5O3
Pureza:
Min. 95%
Peso molecular:
549.54 g/mol
Ref: 3D-FU165699
| 1mg | 645,00 € | |
| 2mg | 820,00 € | |
| 5mg | 1.061,00 € | |
| 10mg | 1.767,00 € |
Entrega estimada en Estados Unidos, el Lunes 29 de Julio de 2024
